The title compound, 3-ethyl-2-methyl-1H-[1,10]phenanthrolin-4-one, C15H14N2O, crystallizes in the monoclinic space group P21/n with unit-cell parameters: a = 8.1941(8), b = 12.3569(12), c = 11.9673(12)Å, b = 105.214(2)˚, Z = 4. The crystal structure was solved by direct methods using single-crystal X-ray diffraction data collected at 100 K and refined by full-matrix least-squares procedures to a final R-value of 0.0577 for 1818 observed reflections. There is a strong intramolecular hydrogen bond between the two phenanthroline N atoms. The characteristic pattern observed in the packing diagram is the appearance of chains of molecules packed together to form well-defined layers.
2-Methyl-1,10-phenanthroline was the first 1,10-phenanthroline reported. 1 There are many examples of the analytical use of 1,10-phenanthroline and its derivatives in biological systems by virtue of their chelating properties. The activity in many cases is due to the ability of 1,10-phenanthroline to complex with metals essential to the functioning of enzymes in living organisms. Some reports, however, indicate that factors not concerned with its ability to bind metal ions are also important. 1,10-Phenanthroline has antitumor properties against sarcoma in mice, and inhibits the induction of carcinoma in rats. Quaternary salts of 6-methyl-1,10-phenanthroline are also carcinostatic.
1,10-Phenthroline is active against many microorganisms. It is bacteriostatic and fungistatic, and is a potent anthelminitic. It possess tuberculostatic activity and is antispermatozoal. 2,9-Dimethyl-1,10-phenanthroline is even more fungistatic than the parent compound. Several methyl and phenyl substituted 1,10-phenanthrolines and their quaternary salts are also highly active against microorganisms, 1,10-phenanthroline has antifibrillatory activity and inhibits gastric secretion.
1,10-Phenanthroline and its derivatives inhibit numerous enzymes. The title compound, 3-ethyl-2-methyl-1H-[1,10]phenanthrolin-4-one, exhibit moderate anti-leishmania activity. 2 To a mixture of 8-aminoquinoline (1 mol) and ethyl ethylacetoacetate (1 mol) in a round-bottomed flask fitted with a reflux condenser and a CaCl2 guard tube, polyphosphuric acid (PPA) was added, and the reaction mixture was heated on a steam bath. Progress of the reaction was monitored by TLC. After the reaction was over it was poured into ice cold water, basified and extracted with chloroform. The title compound was purified by column chromatography, followed by crystallization from acetone as fine crystals, m.p. 249˚C. The chemical structure is shown in Fig. 1 . Hydrogen atoms were located from a difference Fourier map and refined along with all of the parameters of the non-hydrogen atoms. The crystal and experimental data are listed in Table 1 . An ORTEP-3 drawing of the molecule is shown in Fig. 2 . Selected bond lengths, bond angles and the geometry of hydrogen bonds are listed in Table 2 .
In the title molecule, the two outer pyridine rings are connected by a phenyl ring, making the whole molecule planar and rigid. The six C-C bond lengths in the phenyl ring lie in the range 1.352(3) -1.439(2)Å with an average value of 1.409(2)Å. The bond angles, N10-C12-C13 and C7-C11-C6, at the junction of rings B and C are, respectively, smaller and greater than 120˚, but the bond angles, N1-C13-C12 and C5-C14-C4, at the junction of rings A and B are, nearly equal to 120˚. The average C-C (1.423 Å) and C-N bonds (1.356 Å) and angles (120˚) within the rings are in agreement with the related structres. [3] [4] [5] The length of the double-bond C4=O4 [1.263(2)Å] is larger than the standard value for the carbonyl group [1.192 Å] , and lengthening of the C4=O4 double bond is due to a strong intermolecular hydrogen bond between N1 and O4. There is a strong intramolecular contact between N10 and the H atom attached to N1. This leads to the formation of a pseudo-fivemembered ring.
Both of the pyridine rings A and C are perfectly planar, with a maximum deviation of 0.008(2)Å for C8. The ethyl group makes a dihedral angle of 89.4(1)˚ with the least-squares plane through the pyridine ring A. The methyl group C15 deviates by -0.039(2)Å from the least-squares plane of this ring. The phenyl ring B is also planar with a maximum deviation of 0.004(2)Å for C5. The pyridine rings A and C make dihedral angles of 1.4(1)˚ and 0.5(1)˚ with the phenyl ring.
Atom N1 acts as a donor for a strong intermolecular N-H·O hydrogen bond with carbonyl atom O4 of the adjacent molecule (see Table 2 for details). This interaction links the molecules into chains that run parallel to the c-axis. The adjacent chain links are rotationally related. The packing of the chains in the crystal is stabilized into a three-dimensional network by C-H·O and C-H·p interactions. The crystal structure is further stabilized by weak p-p stacking interactions between two adjacent phenyl rings in an offset arrangement. Details of p-p interactions are given in Table 3 . Table 2 Selected bond lengths (Å), bond angles (˚) and hydrogen bonds Symmetry Code: (i) 1/2+x, 1/2-y, 1/2+z (ii) 1/2-x, -1/2+y, 1/2-z (iii) 3/2-x, 1/2+y, 1/2-z (iv) -1+x, y, z Cg1, Cg2, Cg3 represents the center of gravity of ring A, C and B. Table 3 Geometry of p-p interactions. Cg2 represents the center of gravity of ring C. CgI·CgJ represents the distance between the ring centroids; CgI·P, the perpendicular distance of the centroid of one ring from the plane of the other; a is the dihedral angle between the planes of rings I and J; b is the angle between normal to the centroid of ring I and the line joining ring centroids; D is the displacement of the centroid of ring J relative to the intersection point of the normal to the centroid of ring I and the least-squares plane of ring J. 
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